Endovascular Treatment Devices Market, By Product (Stents, Balloon Catheters, and Inferior Vena Cava Filters), By Procedure, By End-User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Endovascular Treatment Devices Market size was valued at US$ 3,450.33 Million in 2024, expanding at a CAGR of 9.50% from 2025 to 2032.
Endovascular treatment devices are specialized medical instruments used in minimally invasive procedures to treat various vascular diseases by accessing blood vessels through small incisions or punctures. These devices include stents, balloon catheters, embolic protection devices, and thrombectomy systems, which are essential for managing conditions such as aneurysms, arterial blockages, and venous thromboembolism. Unlike traditional open surgeries, endovascular treatments provide a less invasive alternative, reducing patient trauma, hospital stays, and recovery times.
The demand for endovascular treatment devices is increasing due to the rising prevalence of cardiovascular and peripheral vascular diseases, driven by factors such as aging populations, sedentary lifestyles, and the growing incidence of obesity and diabetes. These devices allow for precision-targeted interventions, improving clinical outcomes and enhancing patient safety. For example, stent grafts reinforce weakened blood vessels, preventing fatal ruptures, while thrombectomy devices efficiently remove life-threatening blood clots with minimal risk.
The significance of these devices lies in their ability to revolutionize the management of complex vascular conditions. Endovascular procedures not only reduce morbidity and mortality rates compared to conventional surgeries but also contribute to lower healthcare costs by minimizing postoperative complications and promoting faster recovery. Additionally, technological advancements in device design and materials continue to enhance the effectiveness and durability of treatments, reinforcing the role of endovascular solutions as a cornerstone of modern vascular care.
Endovascular Treatment Devices Market- Market Dynamics
Rising Prevalence of Vascular Diseases Driving Demand for Endovascular Treatments
The increasing prevalence of vascular diseases, including peripheral artery disease (PAD), aortic aneurysms, and venous thromboembolism (VTE), is driven by aging populations, sedentary lifestyles, and risk factors such as obesity, hypertension, and diabetes. According to the World Health Organization (WHO), cardiovascular diseases, which encompass vascular disorders, are responsible for nearly 17.9 million deaths annually, accounting for 32% of all global deaths.
As the number of patients requiring effective vascular interventions continues to grow, there is an increasing demand for advanced treatment options to restore blood flow and prevent life-threatening complications. Endovascular devices, such as stent grafts, balloon catheters, and thrombectomy systems, provide minimally invasive solutions for managing these conditions. Compared to traditional open surgeries, these devices offer safer, more efficient treatments, leading to shorter hospital stays, faster recovery times, and a lower risk of postoperative complications.
Additionally, government initiatives aimed at enhancing healthcare infrastructure and increasing awareness about early diagnosis and treatment of vascular diseases further support market growth. National health campaigns focused on cardiovascular risk reduction and the integration of modern vascular care technologies are fostering the adoption of endovascular treatment solutions worldwide.
Endovascular Treatment Devices Market- Segmentation Analysis:
The Global Endovascular Treatment Devices Market is segmented on the basis of Product, Procedure, End-User and Region.
The endovascular treatment devices market is segmented by Product into Stents, Balloon Catheters, and Inferior Vena Cava (IVC) Filters. Stents hold a significant market share due to their widespread application in treating arterial blockages, effectively restoring blood flow and reducing the risk of restenosis. Advancements in drug-eluting and bioresorbable stents have further improved long-term patient outcomes, reinforcing their market dominance.
In terms of End-User, the market is categorized into Hospitals, Ambulatory Surgical Centers (ASCs), and Specialty Clinics. Hospitals lead the market, equipped with advanced medical infrastructure, specialized vascular care units, and skilled professionals essential for performing complex endovascular procedures. The higher patient inflow and availability of post-operative care facilities make hospitals the preferred choice for vascular treatments.
ASCs are also experiencing growth in the endovascular treatment devices market. As of 2022, there are over 6,300 Medicare-certified ASCs in the United States, with more than 18,000 operating rooms, reflecting an annual growth rate of 2.1%. This expansion indicates a rising preference for minimally invasive procedures performed in outpatient settings, contributing to the demand for endovascular devices.
The increasing prevalence of vascular diseases, such as peripheral artery disease and aortic aneurysms, underscores the need for effective interventions. According to the World Health Organization, cardiovascular diseases, which include vascular disorders, account for nearly 17.9 million deaths annually, representing 32% of all global deaths. This growing burden highlights the critical role of endovascular treatment devices in managing these conditions.
Government initiatives aimed at improving healthcare infrastructure and promoting early diagnosis and treatment of vascular diseases further support market expansion. National health campaigns focusing on cardiovascular risk reduction and the integration of modern vascular care technologies are fostering growth in the endovascular treatment devices market.
Endovascular Treatment Devices Market- Geographical Insights
North America leads the global market, driven by a high incidence of vascular diseases, an advanced healthcare system, and widespread adoption of minimally invasive procedures. According to the American Heart Association, cardiovascular diseases remain a leading cause of death in the United States, further fueling demand for innovative endovascular solutions. Additionally, favorable reimbursement policies and continuous product advancements reinforce the region’s market dominance.
Europe holds a substantial market share, supported by an aging population, increased healthcare spending, and government initiatives promoting cardiovascular disease management. Countries such as Germany, the United Kingdom, and France significantly contribute to market growth due to their robust healthcare systems and technological advancements in medical devices.
The Asia-Pacific region is expected to experience the fastest growth, driven by rising healthcare awareness, an increasing prevalence of peripheral artery diseases, and improvements in healthcare infrastructure. Rapid urbanization, lifestyle changes, and a growing elderly population in countries like China, India, and Japan further contribute to market expansion. Additionally, government investments in modern healthcare facilities and greater access to medical treatments are accelerating demand for endovascular treatment devices across the region.
Endovascular Treatment Devices Market- Competitive Landscape:
The endovascular treatment devices market is highly competitive, with key players focusing on innovation, product differentiation, and strategic collaborations to strengthen their market presence. Companies are investing heavily in research and development to introduce next-generation devices with enhanced safety, efficacy, and durability, including drug-eluting and bioresorbable stents, advanced embolic protection systems, and novel thrombectomy devices. To meet the growing demand for minimally invasive solutions, market participants are expanding their product portfolios to address a wide range of vascular conditions. Strategic partnerships, mergers, and acquisitions are commonly used to accelerate technological advancements, expand geographic reach, and enhance market penetration. Additionally, companies are prioritizing regulatory approvals and clinical trials to ensure compliance with global healthcare regulations and maintain a competitive edge. The market is also witnessing a shift toward AI-driven diagnostics and smart endovascular technologies, which are improving precision and personalized treatment. Factors such as competitive pricing, robust distribution networks, and strong post-sales support play crucial roles in maintaining market share. As demand for advanced vascular treatment solutions continues to grow, competition is expected to intensify, driving further innovation and improved patient outcomes in this rapidly evolving sector.
Recent Developments
June 2024: Boston Scientific announced an agreement to acquire Silk Road Medical, Inc., a company specializing in transcarotid artery revascularization (TCAR) devices. This minimally invasive procedure aims to prevent strokes in patients with carotid artery disease, further strengthening Boston Scientific’s vascular portfolio.
July 2024: Sensome signed an exclusive distribution agreement with Cosmotec in Japan for its clot-sensing guidewire. This partnership allows Cosmotec to commercialize Sensome’s real-time blood clot detection technology during endovascular procedures, enhancing clinical decision-making and patient outcomes. The agreement marks a key milestone in Sensome’s expansion into the Japanese market.
November 2024: Solaris Endovascular, Inc. launched in the U.S., focusing on developing solutions for dialysis access in end-stage kidney disease and peripheral artery disease treatment. The company introduced its flagship product, the Solaris SX vascular stent graft, designed to reduce restenosis and improve patency using advanced technology.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Boston Scientific Corporation
Medtronic plc
Abbott Laboratories
Johnson & Johnson Services, Inc.
Terumo Corporation
Cook Group Incorporated
Edwards Lifesciences Corporation
W. L. Gore & Associates, Inc.
Philips Healthcare
Siemens Healthineers
Cardinal Health
Stryker Corporation
Baxter International Inc.
Asahi Intecc Co., Ltd.
Others
GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
Stents
Balloon Catheters
Inferior Vena Cava Filters
Others
GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PROCEDURE - MARKET ANALYSIS, 2019 - 2032
Angioplasty
Aneurysm Repair
Thrombectomy
Others
GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- Uk
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest Of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest Of Apac
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest Of Latam
The Middle East And Africa
- Saudi Arabia
- Uae
- Israel
- Turkey
- Algeria
- Egypt
- Rest Of Mea
TABLE OF CONTENT
1. Endovascular Treatment Devices Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Endovascular Treatment Devices Market Snippet by Product
2.1.2. Endovascular Treatment Devices Market Snippet by Procedure
2.1.3. Endovascular Treatment Devices Market Snippet by End-User
2.1.4. Endovascular Treatment Devices Market Snippet by Country
2.1.5. Endovascular Treatment Devices Market Snippet by Region
2.2. Competitive Insights
3. Endovascular Treatment Devices Key Market Trends
3.1. Endovascular Treatment Devices Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Endovascular Treatment Devices Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Endovascular Treatment Devices Market Opportunities
3.4. Endovascular Treatment Devices Market Future Trends
4. Endovascular Treatment Devices Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Endovascular Treatment Devices Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Endovascular Treatment Devices Market Landscape
6.1. Endovascular Treatment Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Endovascular Treatment Devices Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Stents
7.1.3. Balloon Catheters
7.1.4. Inferior Vena Cava Filters
7.1.5. Others
8. Endovascular Treatment Devices Market – By Procedure
8.1. Overview
8.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
8.1.2. Angioplasty
8.1.3. Aneurysm Repair
8.1.4. Thrombectomy
8.1.5. Others
9. Endovascular Treatment Devices Market – By End-User
9.1. Overview
9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
9.1.2. Hospitals
9.1.3. Ambulatory Surgical Centers
9.1.4. Specialty Clinics
9.1.5. Others
10. Endovascular Treatment Devices Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Endovascular Treatment Devices Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Endovascular Treatment Devices Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Endovascular Treatment Devices Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Endovascular Treatment Devices Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Endovascular Treatment Devices Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Endovascular Treatment Devices Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Boston Scientific Corporation
11.2.2. Medtronic plc
11.2.3. Abbott Laboratories
11.2.4. Johnson & Johnson Services, Inc.
11.2.5. Terumo Corporation
11.2.6. Cook Group Incorporated
11.2.7. Edwards Lifesciences Corporation
11.2.8. W. L. Gore & Associates, Inc.
11.2.9. Philips Healthcare
11.2.10. Siemens Healthineers
11.2.11. Cardinal Health
11.2.12. Stryker Corporation
11.2.13. Baxter International Inc.
11.2.14. Asahi Intecc Co., Ltd.
11.2.15. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
